Señales en vivo de DNA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 12:24):

Stats
Volumen de hoy	55.49M
Volumen promedio	26.69M
Capitalización de mercado	2.09B
EPS	$0 ( 2024-02-29 )
Próxima fecha de ganancias	( $-0.0800 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.11
ATR14	$0.00500 (0.52%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Dmytruk Mark E.	Sell	22 916	Restricted Stock Units
2024-04-01	Dmytruk Mark E.	Buy	1 634	Class A Common Stock
2024-04-01	Dmytruk Mark E.	Buy	22 916	Class A Common Stock
2024-04-01	Dmytruk Mark E.	Buy	18 125	Class A Common Stock
2024-04-01	Dmytruk Mark E.	Buy	65 448	Class A Common Stock

INSIDER POWER
-25.19
Last 100 transactions
Buy: 2 333 675 \| Sell: 4 285 014

Volumen Correlación

Largo: 0.26 (neutral)

Corto: 0.83 (strong)

Signal:(35.473) Same movement expected

Ginkgo Bioworks Holdings, Correlación

10 Correlaciones Más Positivas
ATTO	0.927
KT	0.92
DHX	0.918
ARMK	0.912
WF	0.911
PDS	0.911
WRBY	0.902
MYTE	0.902
AVYA	0.899
AMRC	0.899

10 Correlaciones Más Negativas
RXN	-0.884
MOG-B	-0.881
DSE	-0.872
COR	-0.872
MSP	-0.87
PSXP	-0.868
AMAM	-0.864
TNK	-0.855
CMO	-0.851
FPAC	-0.851

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ginkgo Bioworks Holdings, Correlación - Moneda/Commodity

-0.33
( neutral )

-0.54
( weak negative )

0.00
( neutral )

-0.52
( weak negative )

0.00
( neutral )

0.36
( neutral )

Ginkgo Bioworks Holdings, Finanzas

Annual	2023
Ingresos:	$251.46M
Beneficio Bruto:	$142.64M (56.73 %)
EPS:	$-0.460

FY	2023
Ingresos:	$251.46M
Beneficio Bruto:	$142.64M (56.73 %)
EPS:	$-0.460

FY	2022
Ingresos:	$477.71M
Beneficio Bruto:	$273.49M (57.25 %)
EPS:	$-1.250

FY	2021
Ingresos:	$313.84M
Beneficio Bruto:	$204.16M (65.05 %)
EPS:	$-1.231

Financial Reports:

No articles found.

Ginkgo Bioworks Holdings,

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.